The present invention relates to novel compounds that are useful for inhibition
and prevention of cell adhesion and cell adhesion-mediated pathologies. This invention
also relates to pharmaceutical formulations comprising these compounds and methods
of using them for inhibition and prevention of cell adhesion and cell adhesion-mediated
pathologies. The compounds and pharmaceutical compositions of this invention can
be used as therapeutic or prophylactic agents. They are particularly well-suited
for treatment of many inflammatory and autoimmune diseases.